Health Trials

About this trial

This study aims to employ a cluster randomized controlled trial to evaluate the effectiveness of an mHealth-Based Multi-faceted Cardiovascular Health Intervention Model among Overweight/Obese Individuals with Cardiometabolic Preconditions, thereby providing theoretical foundations and practical guidance for the prevention and management of this population.

Eligibility criteria

Qualifiers

Age >= 18 years, no gender restriction;

Overweight and obesity: Body Mass Index (BMI) 24.0-32.4 kg/m², or waist circumference >= 90 cm for males and >= 85 cm for females;

Disqualifiers

Secondary obesity diagnosed by doctors in secondary or higher-level medical institutions;

Cardiovascular and cerebrovascular diseases, including myocardial infarction, stroke, heart failure, arrhythmia; or having received coronary intervention therapy, cardiac surgery, etc.; or with a 10-year high risk of cardiovascular disease;

Diseases seriously affecting survival, such as malignant tumors, AIDS, hepatic and renal failure;

Pregnancy, lactation period, or women who may become pregnant within one year;

Trial design

Treatments tested in this trial

  • Smartwatch-Based Multi-Faceted Behavioral Intervention Model Led by Exercise and Dietary Interventions, Supported by Primary Medical Staff, Along with the Distribution of Health Education Manuals
  • Face-to-face health education sessions

Treatment groups

1,400 Participants
are divided into 2 treatment groups

Locations

3
Beijing Chao Yang Hospital100013, BeijingBeijing Municipality, China
Cangzhou Central Hospital061012, CangzhouHebei, China
Health Community Group of Yuhuan People's Hosptial317608, YuhuanZhejiang, China

Sponsors and collaborators

Beijing Anzhen Hospital

Lead sponsor

Beijing Chao Yang Hospital

Collaborator

Cangzhou Central Hospital

Collaborator

Health Community Group of Yuhuan People's Hosptial

Collaborator

Source ClinicalTrials.gov